This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations of Yueteng Chen in Hypoglycemic Agents
Introduction
Yueteng Chen is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypoglycemic agents. His innovative work focuses on the effective use of alkaloids derived from mulberry twigs.
Latest Patents
Yueteng Chen holds a patent titled "Use of the effective fraction of alkaloids from mulberry twig in preparing hypoglycemic agents." This invention relates to an effective fraction of alkaloids, which is prepared from mulberry twig. The active ingredients consist of a composition of alkaloids, with the total alkaloids percentage being 50% or more by weight in the effective fraction. Additionally, the compound 1-deoxynojirimycin constitutes 30% or more by weight of the total alkaloids. The preparation process involves extracting the mulberry twig using solvents, followed by alcohol precipitation or flocculation to remove impurities, and then concentrating and purifying the extract through resin chromatography.
Career Highlights
Yueteng Chen is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research and development activities. His work has been instrumental in advancing the understanding and application of natural compounds in medicine.
Collaborations
Some of his notable coworkers include Mingzhi Xie and Sujuan Sun, who have collaborated with him on various research projects.
Conclusion
Yueteng Chen's innovative approach to utilizing alkaloids from mulberry twigs has the potential to significantly impact the development of hypoglycemic agents. His contributions to the field of pharmaceuticals highlight the importance of natural compounds in medical advancements.